COMP <GO>
NGVT vs WDFC // EV/EBITDA & P/E VALUATION
Ingevity Corporation (NYSE) VS. WD-40 Company (NASDAQ) • 15-METRIC TALLY: NGVT 4
— WDFC 8
▲ EV/EBITDA & P/E VALUATION LEADER: NGVT
LAST: $75.37 (+1.62%) • MKT CAP: $2.59B
valuation
6.0x
LAST: $219.41 (+2.49%) • MKT CAP: $2.94B
valuation
27.6x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (NGVT VS. WDFC)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | NGVT | WDFC | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 39.50% | 55.10% | -15.60 | WDFC | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 85.00% | 27.20% | +57.80 | NGVT | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | 6.0x | 27.6x | -21.60 | NGVT | /valuation <GO> |
| Free Cash Flow Yield | 12.78% | 2.84% | +9.94 | NGVT | /fcf-yield <GO> |
| Operating Margin | 35.90% | 16.70% | +19.20 | NGVT | /operating-margins <GO> |
| Net Profit Margin | -14.30% | 14.70% | -29.00 | WDFC | /net-margins <GO> |
| Revenue Growth (YoY) | -2.70% | 5.00% | -7.70 | WDFC | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 1.71% | -1.71 | WDFC | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.93 | 13.24 | -10.31 | WDFC | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 8/9 | -2.00 | WDFC | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.0 | 64.6 | -2.61 | WDFC | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | 30.0x | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.59B | $2.94B | -$347.4M | WDFC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | NGVT REV | WDFC REV | NGVT GROSS % | WDFC GROSS % | NGVT FCF | WDFC FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.17B | $620.0M | 39.5% | 55.1% | $331.2M | $83.4M |
| FY 2024 | $1.20B | $590.6M | 38.7% | 53.4% | $128.6M | $87.8M |
| FY 2023 | $1.22B | $537.3M | — | — | $205.1M | $98.4M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
NGVT // BETA —
WDFC // BETA —